However, in the absence of PD-1, tumor cells express the NK cell inhibitory receptor CD161, highlighting the importance of NK-mediated immune surveillance and the necessity for leukemic cells to evade the host’s NK immune response in order to exit the bone marrow. The gene discussed is KLRB1; the disease is neoplasm.